Today, leading cancer charity Macmillan Cancer Support announces HUMA as the winner of a £75,000 investment to further develop its systemic anti-cancer therapy Digital Checklist app, aimed to help improve the experience of cancer patients across the UK.
HUMA’s SACT (systemic anti-cancer therapy digital checklist allows patients to share health information via a mobile app which in turn allows clinicians to monitor their health remotely.
The app enables patients to answer a digital pre-screening checklist and share information such as vital signs and symptoms with clinicians from the comfort of their home. Clinicians can then review patient checklist answers and health data remotely to understand if they are ready to receive SACT and what they may need for their recovery. Currently, when cancer patients are pre-screened to check their health before receiving SACT, this is usually done over the telephone or in a physical appointment. This can be inconvenient for some patients and can add to the workload for clinicians.
The innovation from HUMA is designed to increase clinical capacity for the delivery of treatment, improve the patient experience and reduce stress for cancer patients. Virtual care has the potential to deliver a quality healthcare service for cancer patients, with the aim of making their experience more convenient, more streamlined, and more closely aligned to their needs. During the COVID-19 pandemic, the adoption of virtual wards and care, as well as remote monitoring, was accelerated. Early evidence suggests feedback from patients and staff has been positive.
HUMA SACT was one of six innovations shortlisted for the Macmillan Innovation Challenge, delivered in partnership with three Health Innovation Networks: Health Innovation East, Health Innovation Kent Surrey Sussex and Health Innovation Yorkshire & Humber. The investment is one of several made as part of Macmillan’s investment portfolio which will invest £3.5 million over the next two years in start- up businesses developing ground-breaking cancer care products and technology.
The HUMA SACT Digital Checklist was co-developed with clinicians from East Suffolk and North Essex NHS Foundation Trust at the Woolverstone Macmillan Centre. The checklist was implemented at the Woolverstone Centre in 2023 and initial feedback suggests it is helping improve patient
experience and enhance clinical capacity. In partnership with Macmillan and the three Health Macmillan Public Innovation Networks, HUMA will now scale the deployment of the technology to increase reach and impact for people with cancer across the UK.
Health Innovation East, Health Innovation Kent Surrey Sussex and Health Innovation Yorkshire & Humber will facilitate introductions within the NHS and provide expertise to deliver a service evaluation gathering real-world evidence.
Anthony Cunliffe, National Lead Medical Adviser at Macmillan Cancer Support says “We’re delighted to announce HUMA as the winner of the Macmillan Health Innovation Challenge 2023. By using pioneering technology, HUMA’s SACT Digital Checklist app could have a transformational effect on cancer care across the UK by increasing clinical capacity and ultimately improving the experience for many cancer patients, by supporting them to have their health monitored in the comfort of their own home. This could reduce the need for them to travel to and from hospital, thus minimising their risk of infection.”
Karanjit Aujla, VP, Partnerships (HUMA): “We are thrilled that HUMA has won the Macmillan Innovation Challenge and are excited to collaborate with Macmillan to scale our digital SACT platform across the NHS. Our digital SACT checklist already shows a promise for increasing capacity and
enhancing both patient and clinician experiences. SACT centers are under unsustainable pressure, and we hope that our solution can help the NHS manage the growing demand more effectively, by streamlining the assessment process and reducing unnecessary burdens on patients. Partnering with Macmillan presents an incredibly exciting opportunity, and together we will work towards improving the experience for many cancer patients and increasing SACT capacity at a critical time for the NHS.”
